Corbus Pharma (CRBP) Sees Continued Momentum

September 14, 2016 11:32 AM EDT
Get Alerts CRBP Hot Sheet
Trade CRBP Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Corbus Pharma (NASDAQ: CRBP) continues to see strong momentum. Shares are up 9% today on volume that is running 10x normal. Shares have more than doubled over the past month and 25% since it announced on Sept 12 that it has completed subject enrollment in its Phase 2 clinical study of Resunab for the treatment of cystic fibrosis ("CF").



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Momentum Movers, Trader Talk

Add Your Comment